Previous Close | 35.02 |
1-Year Change | -12.49% |
6-Months Change | 7.99% |
3-Months Change | -0.99% |
Moving Avg (50d) | 34.698 |
Moving Avg (200d) | 32.44 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 299.1M |
Beta (3-Years) | 1.2 |
Revenue Growth (ttm) | 66.71% |
Net Profit Margin (ttm) | -13.05% |
Return On Assets (ttm) | -10.83% |
EPS (ttm) | -1.01 |
PE Ratio (ttm) | -34.67 |
Dividend Yield | % |
Asset Description: | Sanara MedTech Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2025-02-13 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
34.32 | 33.269 | 32.569 | 31.518 | 29.767 | 28.016 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |